Bayer was ordered to pay more than $2 billion by a jury in a Georgia state court in the latest legal case surrounding alleged ...

Bayer Weedkiller Lawsuit Dismissed By Australian Judge: Insufficient Evidence Linking Roundup To Blood Cancer Australian judge dismisses class action lawsuit against Bayer for Roundup causing ...

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

BAYRY subsidiary Vividion Therapeutics doses the first patient in a phase I study on VVD-159642 to treat advanced solid ...

The uncertainty caused by ongoing Roundup litigation is also a major hangover on the stock ... Bayer Aktiengesellschaft price-consensus-eps-surprise-chart | Bayer Aktiengesellschaft Quote Bayer ...

Bayer's stock surged 24.5% since December 2024, yet remains a speculative investment due to significant risks like high debt and ongoing litigation. 2024 annual results showed a 2.2% sales decline ...

At the time of writing, shares in Bayer were up 12.38% at €29.67, after the company won a legal battle to limit liability ...

Bayer CEO: 2025 Will Be 'Most Difficult' Year In Turnaround Plan, Expects Improved Performance From 2026 Onwards Bayer reported Q4 adjusted EPS of $0.28, missing estimates, but sales beat ...